Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1636 1639 1675 1678 1682 1684
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16817458 | CROSS-LINKED EPITOPES AND METHODS OF USE THEREOF | Final Rejection | REGENERON PHARMACEUTICALS, INC. |
| 17182044 | GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS | Final Rejection | Trustees of Boston University |
| 18940636 | PROCESSES AND SYSTEMS FOR PREPARATION OF NUCLEIC ACID SEQUENCING LIBRARIES AND LIBRARIES PREPARED USING SAME | Non-Final OA | 10x Genomics, Inc. |
| 18659813 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | Final Rejection | Encodia, Inc. |
| 17642800 | Micro-Radiobinding Assays for Ligand Screening | Non-Final OA | AC Immune SA |
| 18250816 | SYNTHETIC LETHALITY-MEDIATED PRECISION ONCOLOGY VIA TUMOR TRANSCRIPTOME | Non-Final OA | The United States of America, as Represented by the Secretary, Dept. of Health and Human Services |
| 18637241 | METHODS, SYSTEMS, AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES | Non-Final OA | Enumera Molecular, Inc. |
| 17702880 | ASSEMBLY OF PROTEIN COMPLEXES ON A CHIP | Non-Final OA | Yeda Research and Development Co. Ltd. |
| 17636288 | METHOD OF QUALIFYING A SUBGROUP OF TARGET BINDING BIOMOLECULES FROM A LARGER GROUP OF TARGET BINDING BIOMOLECULES FOR ANALYSIS | Non-Final OA | Cytiva Sweden AB |
| 17554956 | SYSTEMS AND METHODS FOR BEAD-BASED ASSAYS IN FERROFLUIDS | Non-Final OA | Ancera, Inc. |
| 17370819 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF SEPSIS USING GAMMA PEPTIDE NUCLEIC ACIDS | Non-Final OA | HELIXBIND, INC. |
| 18339429 | METHODS OF IDENTIFYING COMPOUNDS FOR INDUCING PROTEIN-PROTEIN INTERACTION | Final Rejection | Oncopia Therapeutics, Inc. d/b/a/ SK Life Science Labs |
| 18025107 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | Non-Final OA | CRYSTALSFIRST GMBH |
| 18025103 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | Non-Final OA | CRYSTALSFIRST GMBH |
| 18025100 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | Non-Final OA | CRYSTALSFIRST GMBH |
| 17297944 | METHOD FOR PREDICTING THE RESPONSE TO CANCER IMMUNOTHERAPY IN CANCER PATIENTS | Non-Final OA | Charité - Universitätsmedizin Berlin |
| 18060218 | METHOD AND SYSTEM FOR GENERATING A PLURALITY OF ANTIBODY SEQUENCES | Non-Final OA | Innoplexus AG |
| 17635778 | BIOLOGICAL TISSUE STAINING REAGENT, BIOLOGICAL TISSUE STAINING KIT AND BIOLOGICAL TISSUE STAINING METHOD | Non-Final OA | CUBICStars, Inc. |
| 17537215 | MESO-SCALE ENGINEERED PEPTIDES AND METHODS OF SELECTING | Non-Final OA | iBio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy